Ticker Details
Fulcrum Therapeutics, Inc.
IPO Date:	July 15, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$437.78M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.39 | 3.91%
Avg Daily Range (30 D):	$0.23 | 3.23%
Avg Daily Range (90 D):	$0.27 | 3.27%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	.54M
Avg Daily Volume (90 D):	.75M

Trade Size
Avg Trade Size (Sh.):	102
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	73

Institutional Trades
Total Institutional Trades:	850
Avg Institutional Trade:	$1.46M
Avg Institutional Trade (30 D):	$.95M
Avg Institutional Trade (90 D):	$1.08M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.52M
Avg Closing Trade (30 D):	$1.05M
Avg Closing Trade (90 D):	$1.09M
Avg Closing Volume:	170.98K

News

Apr 27, 2026 @ 11:00 AM Fulcrum Therapeutics Announces Recent Business Hig... Source: Not Specified

Mar 19, 2026 @ 12:00 PM MedicAlert Foundation, Sickle Cell Disease Associa... Source: Na

Feb 24, 2026 @ 12:00 PM Fulcrum Therapeutics Announces Positive 12-Week Re... Source: Na

Dec 12, 2025 @ 2:00 PM Firmware Signing Platform Market Size to Reach USD... Source: Sns Insider

Dec 10, 2025 @ 12:48 PM Fulcrum Therapeutics Announces Pricing of Upsized ... Source: Globe Newswire

Financials
	TTM	Q1 2026	Q2 2025
Basic EPS		$-.25	$-.28
Diluted EPS		$-.25	$-.28
Revenue		$M	$M
Gross Profit
Net Income / Loss		$-18.89M	$-17.3M
Operating Income / Loss		$-22.19M	$-19.82M
Cost of Revenue
Net Cash Flow		$-147.27M	$-15.62M
PE Ratio